SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Congenital Heart Fu-
tures Reauthorization Act of 2024’’. 
SEC. 2. REAUTHORIZATION OF NATIONAL CONGENITAL 
HEART DISEASE RESEARCH, SURVEILLANCE, 
AND AWARENESS PROGRAM. 
Section 399V–2 of the Public Health Service Act (42 
U.S.C. 280g–13) is amended— 
(1) by redesignating subsections (f) and (g) as 
subsections (g) and (h), respectively; 
(2) by inserting after subsection (e) the fol-
lowing: 
‘‘(f) REPORT AND STRATEGY.— 
‘‘(1) REPORT.—Not later than 2 years after the 
date of enactment of the Congenital Heart Futures 
Reauthorization Act of 2024, the Secretary shall 
issue a report to the Committee on Energy and 
Commerce of the House of Representatives and the 
Committee on Health, Education, Labor, and Pen-
sions of the Senate including the following: 
‘‘(A) A description of past and present ac-
tivities of the Department of Health and 
Human Services to increase awareness and 
knowledge of the public with respect to con-
genital heart disease, including efforts to ad-
dress the lifelong needs of congenital heart dis-
ease patients. 
‘‘(B) An assessment of past and present 
activities of the Department of Health and 
Human Services to increase education and 
training of health care providers with respect to 
congenital heart disease, including efforts to ad-
dress the lifelong needs of congenital heart dis-
ease patients. 
‘‘(C) A description of the current work-
force capacity in the United States of health 
care providers who treat adult patients living 
with congenital heart disease. 
‘‘(2) STRATEGY.— 
‘‘(A) DEVELOPMENT; SUBMISSION TO CON-
GRESS.—Not later than 1 year after submitting 
the report required by paragraph (1), the Sec-
retary shall develop and submit to Congress a 
strategy for improving efforts to increase 
awareness and knowledge of the public and edu-
cation and training of health care providers 
with respect to congenital heart disease. Such 
strategy 
shall 
include 
findings 
and 
rec-
ommendations to—
‘‘(i) address any public awareness and 
research gaps and opportunities related to 
the lifelong needs of congenital heart dis-
ease patients, including long-term health 
outcomes, quality of life, mental health, 
and health care utilization; 
‘‘(ii) address any shortages in the cur-
rent workforce of health care providers 
who treat adult patients living with con-
genital heart disease, which may include 
strategies to enhance fellowship training 
programs or other continuing education 
programs; and 
‘‘(iii) foster collaboration and dissemi-
nation of information across Federal agen-
cies, health care providers, researchers, 
and patient organizations. 
‘‘(B) CONSULTATION.—In developing the 
strategy under subparagraph (A), the Secretary 
shall, as appropriate, consult with qualified 
stakeholder groups, including patient organiza-
tions, health care professionals, research enti-
ties, health insurance providers, accrediting or-
ganizations, and relevant Federal agencies, in-
cluding the Centers for Disease Control and
Prevention, the National Institutes of Health, 
and the Health Resources and Services Admin-
istration.’’; and 
(3) in subsection (h), as so redesignated, by 
striking ‘‘2020 through 2024’’ and inserting ‘‘2025 
through 2029’’. 
Passed the House of Representatives September 23, 
2024. 
Attest: 
Clerk.
118TH CONGRESS 
2D SESSION 
H. R. 7189 
AN ACT 
To amend the Public Health Service Act to reau-
thorize a national congenital heart disease re-
search, surveillance, and awareness program, and 
for other purposes.